Cargando…

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when investigating patients suspected of having antiphospholipid syndrome (APS). aPL detection is currently performed by solid-phase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radin, Massimo, Cecchi, Irene, Foddai, Silvia Grazietta, Rubini, Elena, Barinotti, Alice, Ramirez, Carlos, Seaman, Andrea, Roccatello, Dario, Mahler, Michael, Sciascia, Savino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766094/ https://www.ncbi.nlm.nih.gov/pubmed/33348782 http://dx.doi.org/10.3390/biomedicines8120622

Ejemplares similares

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation
por: Radin, Massimo, et al.
Publicado: (2021)

Serum Biomarkers of Renal Fibrosis: A Systematic Review
por: Barinotti, Alice, et al.
Publicado: (2022)

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing
por: Barinotti, Alice, et al.
Publicado: (2020)

New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing
por: Foddai, Silvia Grazietta, et al.
Publicado: (2023)

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
por: Sciascia, Savino, et al.
Publicado: (2022)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review
por: Arbrile, Marta, et al.
Publicado: (2023)

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
por: Sciascia, Savino, et al.
Publicado: (2023)

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
por: Sciascia, Savino, et al.
Publicado: (2022)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp—A Usability Study
por: Sciascia, Savino, et al.
Publicado: (2020)

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

Targeting of MuLV Gag to the plasma membrane is mediated by PI(4,5)P(2 )and PhosphatidylSerine
por: Hamard-Peron, E, et al.
Publicado: (2009)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It “Idiopathic”?
por: Radin, Massimo, et al.
Publicado: (2018)

Recent advances in the management of systemic lupus erythematosus
por: Sciascia, Savino, et al.
Publicado: (2018)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Crystal structures of phosphatidyl serine synthase PSS reveal the catalytic mechanism of CDP-DAG alcohol O-phosphatidyl transferases
por: Centola, Martin, et al.
Publicado: (2021)

Role of Phosphatidyl-Serine in Bone Repair and Its Technological Exploitation
por: Merolli, Antonio, et al.
Publicado: (2009)

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App
por: Radin, Massimo, et al.
Publicado: (2022)

Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease
por: Arbrile, Marta, et al.
Publicado: (2021)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease
por: Sciascia, Savino, et al.
Publicado: (2023)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

Renal involvement as a unique manifestation of hemophagocytic syndrome
por: Roccatello, Dario, et al.
Publicado: (2022)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

Mercury Induces the Externalization of Phosphatidyl-Serine in Human Renal Proximal Tubule (HK-2) Cells
por: Sutton, Dwayne J., et al.
Publicado: (2007)

Determination of pH Effects on Phosphatidyl-Hydroxytyrosol and Phosphatidyl-Tyrosol Bilayer Behavior
por: Evans, Kervin O., et al.
Publicado: (2018)

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
por: Sciascia, Savino, et al.
Publicado: (2016)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine
Publicado: (1994)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
por: Sciascia, Savino, et al.
Publicado: (2021)

Low frequency of phosphatidylserine/prothrombin complex antibodies in a cohort of patients with anticardiolipin antibodies and recent thrombosis
por: Locht, H
Publicado: (2003)

Establishment of a rat model of thrombosis induced by intravenous injection of anti-phosphatidylserine–prothrombin complex antibody
por: Yamada, Mai, et al.
Publicado: (2017)

A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response
por: Rossi, Daniela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iu6ngueuf7qn87vp7na3u39b62